Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories u.S. FDA 510(k) Device Clearances — Abbott
U.S. FDA openFDA Device Clearances, Approvals & Recalls API
Latest, FY2025
29
Period ended Dec 31, 2025
Change on a year earlier
+81.3%
16 in FY2024
History
12 years
Since FY2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up u.s. fda 510(k) device clearances — abbott
- U.S. FDA 510(k) Device Clearances — Total U.S. MedTech Industry3,225 · FY2025
- U.S. FDA Premarket Approvals (PMA Original & Supplements) — Abbott259 · FY2025
- U.S. FDA Premarket Approvals (PMA) — Total U.S. MedTech Industry2,222 · FY2025
- U.S. FDA Medical Device Recall Events — Abbott30 · FY2025
- U.S. FDA Enforcement Recall Actions — Abbott35 · FY2025
Cite this data
StockData. (2026). Abbott Laboratories U.S. FDA 510(k) Device Clearances — Abbott, annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-510k-co
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.